These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 21159908
1. Antiretroviral therapy for control of the HIV-associated MDR and XDR tuberculosis epidemic in South Africa. Lawn SD, Wood R. Am J Respir Crit Care Med; 2010 Dec 15; 182(12):1567; author reply 1568-9. PubMed ID: 21159908 [No Abstract] [Full Text] [Related]
2. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G, Tugela Ferry Care and Research (TF CARES) Collaboration. J Infect Dis; 2007 Dec 01; 196 Suppl 3():S482-90. PubMed ID: 18181698 [Abstract] [Full Text] [Related]
3. The emerging crisis of drug-resistant tuberculosis in South Africa: lessons from New York City. Murphy RA. Clin Infect Dis; 2008 Jun 01; 46(11):1729-32. PubMed ID: 18426372 [Abstract] [Full Text] [Related]
4. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Willcox P, John MA, Reubenson G, Govindasamy D, Wong M, Padanilam X, Dziwiecki A, van Helden PD, Siwendu S, Jarand J, Menezes CN, Burns A, Victor T, Warren R, Grobusch MP, van der Walt M, Kvasnovsky C. Lancet; 2010 May 22; 375(9728):1798-807. PubMed ID: 20488525 [Abstract] [Full Text] [Related]
5. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend. Rajasekaran S, Chandrasekar C, Mahilmaran A, Kanakaraj K, Karthikeyan DS, Suriakumar J. J Indian Med Assoc; 2009 May 22; 107(5):281-2, 284-6. PubMed ID: 19886382 [Abstract] [Full Text] [Related]
6. XDR tuberculosis in South Africa: old questions, new answers. Migliori GB, Sotgiu G. Lancet; 2010 May 22; 375(9728):1760-1. PubMed ID: 20488526 [No Abstract] [Full Text] [Related]
7. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting. Vella V, Racalbuto V, Guerra R, Marra C, Moll A, Mhlanga Z, Maluleke M, Mhlope H, Margot B, Friedland G, Shah NS, Gandhi NR. Int J Tuberc Lung Dis; 2011 Sep 22; 15(9):1170-5, i. PubMed ID: 21943840 [Abstract] [Full Text] [Related]
8. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH, Tugela Ferry Care and Research (TF CARES) Collaboration. Am J Respir Crit Care Med; 2010 Jan 01; 181(1):80-6. PubMed ID: 19833824 [Abstract] [Full Text] [Related]
9. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination. Koenig R. Science; 2008 Feb 15; 319(5865):894-7. PubMed ID: 18276863 [No Abstract] [Full Text] [Related]
10. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. Int J Tuberc Lung Dis; 2008 Jan 15; 12(1):99-104. PubMed ID: 18173885 [Abstract] [Full Text] [Related]
11. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Streicher EM, Müller B, Chihota V, Mlambo C, Tait M, Pillay M, Trollip A, Hoek KG, Sirgel FA, Gey van Pittius NC, van Helden PD, Victor TC, Warren RM. Infect Genet Evol; 2012 Jun 15; 12(4):686-94. PubMed ID: 21839855 [Abstract] [Full Text] [Related]
13. Extensively drug-resistant tuberculosis: new strains, new challenges. Banerjee R, Schecter GF, Flood J, Porco TC. Expert Rev Anti Infect Ther; 2008 Oct 08; 6(5):713-24. PubMed ID: 18847407 [Abstract] [Full Text] [Related]
14. Tuberculosis control in South Africa--will HAART help? Lawn SD, Wood R. S Afr Med J; 2006 Jun 08; 96(6):502-4. PubMed ID: 16841129 [No Abstract] [Full Text] [Related]
15. An updated view on tuberculous lymphadenitis in the context of HIV epidemic as well as multidrug and extensively drug-resistant tuberculosis. Mrówka-Kata K, Namysłowski G, Czecior E, Sowa P, Iwańska J. Otolaryngol Pol; 2012 Jun 08; 66(3):176-80. PubMed ID: 22748677 [Abstract] [Full Text] [Related]
16. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa. Andrews JR, Gandhi NR, Moodley P, Shah NS, Bohlken L, Moll AP, Pillay M, Friedland G, Sturm AW, Tugela Ferry Care and Research Collaboration. J Infect Dis; 2008 Dec 01; 198(11):1582-9. PubMed ID: 18847372 [Abstract] [Full Text] [Related]
17. Reversal of misfortunes. Cohen J. Science; 2013 Feb 22; 339(6122):898-903. PubMed ID: 23430629 [No Abstract] [Full Text] [Related]
18. The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa. De Cock KM, Marston B. Am J Respir Crit Care Med; 2005 Jul 01; 172(1):3-4. PubMed ID: 15980107 [No Abstract] [Full Text] [Related]
19. Drug-resistant and extensively drug-resistant tuberculosis in southern Africa. Grobusch MP. Curr Opin Pulm Med; 2010 May 01; 16(3):180-5. PubMed ID: 20154624 [Abstract] [Full Text] [Related]
20. Extensively drug resistant tuberculosis in a HIV-infected patient in a UK hospital. Flavell S, Eder M, Beaton RK, John L. Int J STD AIDS; 2013 Jan 01; 24(1):63-6. PubMed ID: 23502313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]